These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 28255251

  • 1. Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration.
    Kukulka M, Nudurupati S, Perez MC.
    Clin Exp Gastroenterol; 2017; 10():47-56. PubMed ID: 28255251
    [Abstract] [Full Text] [Related]

  • 2. Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringe.
    Kukulka M, Nudurupati S, Perez MC.
    Clin Exp Gastroenterol; 2018; 11():381-389. PubMed ID: 30323643
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole.
    Kukulka M, Nudurupati S, Perez MC.
    Therap Adv Gastroenterol; 2016 Nov; 9(6):759-769. PubMed ID: 27803731
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule.
    Kukulka M, Nudurupati S, Perez MC.
    Therap Adv Gastroenterol; 2016 Nov; 9(6):770-780. PubMed ID: 27803732
    [Abstract] [Full Text] [Related]

  • 5. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
    Disanto AR, Golden G.
    Clin Drug Investig; 2009 Nov; 29(8):539-49. PubMed ID: 19591515
    [Abstract] [Full Text] [Related]

  • 6. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
    Stark JG, Engelking D, McMahen R, Sikes C.
    Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.
    Damle B, Duczynski G, Jeffers BW, Crownover P, Coupe A, LaBadie RR.
    Clin Ther; 2014 Feb 01; 36(2):236-44. PubMed ID: 24447534
    [Abstract] [Full Text] [Related]

  • 8. Enhancing drug administration flexibility: evaluation of pharmacokinetic properties of tegoprazan orally disintegrating tablet (ODT) administered via nasogastric tube or oral dosing.
    Kim HS, Choi YK, Oh M, Cho YS, Ghim JL.
    Transl Clin Pharmacol; 2024 Jun 01; 32(2):98-106. PubMed ID: 38974342
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, Ren J, Li X, Zou Q.
    Clin Ther; 2009 Oct 01; 31(10):2242-8. PubMed ID: 19922895
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb 01; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
    Weisler RH, Stark JG, Sikes C.
    Clin Pharmacol Drug Dev; 2018 Feb 01; 7(2):160-167. PubMed ID: 28544344
    [Abstract] [Full Text] [Related]

  • 15. Bioequivalence of Esaxerenone Conventional Tablet and Orally Disintegrating Tablet: Two Single-Dose Crossover Studies in Healthy Japanese Men.
    Kurata A, Eto T, Tsutsumi J, Igawa Y, Nishikawa Y, Ishizuka H.
    Clin Pharmacol Drug Dev; 2022 Aug 01; 11(8):957-965. PubMed ID: 35315257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.
    Erdman K, Stypinski D, Combs M, Witt P, Stiles M, Pollock S.
    Pharmacotherapy; 2007 Aug 01; 27(8):1120-4. PubMed ID: 17655512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.